This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: The Mclean Hospital Corporation. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: David Yue-Wei Lee: Innovator in Salvinorin Derivatives
Introduction
David Yue-Wei Lee is a notable inventor based in Cambridge, MA. He has made significant contributions to the field of pharmacology, particularly through his innovative work on salvinorin derivatives. His research focuses on the therapeutic potential of these compounds in treating mood disorders.
Latest Patents
David Yue-Wei Lee holds a patent for "Salvinorin derivatives and uses thereof." This invention features salvinorin compositions that are selective for kappa opioid receptors. The methods outlined in the patent include treating mania using a selective kappa receptor agonist and addressing mood disorders, such as depressive and manic disorders, with salvinorin compositions. He has 1 patent to his name.
Career Highlights
David is affiliated with The McLean Hospital Corporation, where he continues to advance his research. His work has implications for understanding and treating complex mood disorders, showcasing his commitment to improving mental health outcomes.
Collaborations
David has collaborated with esteemed colleagues, including Cécile Béquin and William A. Carlezon. Their combined expertise enhances the research environment and fosters innovative approaches to mental health treatment.
Conclusion
David Yue-Wei Lee is a pioneering inventor whose work on salvinorin derivatives holds promise for the treatment of mood disorders. His contributions to pharmacology reflect a dedication to advancing mental health therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile